ASF outbreak lifts Komipharm...Biodyne gains spotlight[K-Bio Pulse] 나은경 2026.02.05 오전 08:10 ABL Bio Slides on Sanofi Reprioritization...Stock Specific Risks Hit Biotechs[K-Bio Pulse] 김새미 2026.02.02 오전 08:10 2% Royalty Shock at Alteogen Ripples Through Korean Biotech[K-Bio Pulse] 김새미 2026.01.22 오전 08:00 Samyang Biopharm Hits Second Straight Upper-Limit Gain [K-Bio Pulse] 김승권 2025.11.26 오전 10:44 ABL Bio Shares Surge on GSK Licensing Deal [K-Bio Pulse] 김진수 2025.04.08 오전 07:58 [Yoo Sung’s Pharma National Wealth Theory] K-Bio’s Cult Leaders and Blind Believers 류성 2025.04.10 오전 08:14 Biotechs buck market slump; CMG Pharma among top gainers[K-Bio Pulse] 유진희 2025.04.17 오전 07:28 BridgeBio Soars, ST Pharm Jumps on U.S. Deals[K-Bio Pulse] 석지헌 2025.07.02 오전 07:36 Medytox vs. the ‘Paper Cat’ MFDS 류성 2025.10.01 오전 07:00 Biotech stocks tumble on rights offerings[K-bio Pulse] 석지헌 2025.08.20 오전 09:00 더 보기 로딩중..